Literature DB >> 11106357

Growth in North American white children with neurofibromatosis 1 (NF1).

J Szudek1, P Birch, J M Friedman.   

Abstract

OBJECTIVE: To analyse the distributions of and generate growth charts for stature and occipitofrontal circumference (OFC) in neurofibromatosis 1 (NF1) patients.
DESIGN: Cross sectional database survey.
SETTING: The National Neurofibromatosis Foundation International Database (NFDB) includes clinical information on NF1 patients from 14 participating centres in North America.
SUBJECTS: A total of 569 white, North American, NF1 patients, 55% female and 45% male. MAIN OUTCOME MEASURES: Stature and OFC measurements of NF1 patients were compared to age and sex matched population norms using z score standardisation and centile curves.
RESULTS: The distributions of stature and OFC are shifted and unimodal among NF1 patients; 13% of patients have short stature (>/=2 standard deviations below the population mean) and 24% have macrocephaly (OFC >/=2 standard deviations above the population mean).
CONCLUSIONS: Alterations of stature and OFC are not limited to NF1 patients with frank short stature or macrocephaly.

Entities:  

Mesh:

Year:  2000        PMID: 11106357      PMCID: PMC1734506          DOI: 10.1136/jmg.37.12.933

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  28 in total

1.  Penetrance and variability in neurofibromatosis: a genetic study of 60 families.

Authors:  J C Carey; J M Laub; B D Hall
Journal:  Birth Defects Orig Artic Ser       Date:  1979

2.  Segregation analysis of peripheral neurofibromatosis (NF1).

Authors:  M Littler; N E Morton
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

3.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.

Authors:  S M Huson; D A Compston; P Clark; P S Harper
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

4.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

5.  Neurofibromatosis type 1 growth charts.

Authors:  M Clementi; S Milani; I Mammi; S Boni; C Monciotti; R Tenconi
Journal:  Am J Med Genet       Date:  1999-12-03

6.  Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study.

Authors:  D Carmi; M Shohat; A Metzker; Z Dickerman
Journal:  Pediatrics       Date:  1999-06       Impact factor: 7.124

7.  Head circumference charts updated.

Authors:  M Ounsted; V A Moar; A Scott
Journal:  Arch Dis Child       Date:  1985-10       Impact factor: 3.791

8.  Induction of oligodendrocyte differentiation by activators of adenylate cyclase.

Authors:  D W Raible; F A McMorris
Journal:  J Neurosci Res       Date:  1990-09       Impact factor: 4.164

9.  von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata.

Authors:  R A Lewis; L P Gerson; K A Axelson; V M Riccardi; R P Whitford
Journal:  Ophthalmology       Date:  1984-08       Impact factor: 12.079

10.  Secular trends in human growth, maturation, and development.

Authors:  A F Roche
Journal:  Monogr Soc Res Child Dev       Date:  1979
View more
  24 in total

1.  Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth.

Authors:  Luca Ferrari; Giulietta Scuvera; Arianna Tucci; Donatella Bianchessi; Francesco Rusconi; Francesca Menni; Elena Battaglioli; Donatella Milani; Paola Riva
Journal:  Hum Genet       Date:  2017-08-03       Impact factor: 4.132

2.  Neurofibromatosis: chronological history and current issues.

Authors:  João Roberto Antônio; Eny Maria Goloni-Bertollo; Lívia Arroyo Trídico
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

3.  Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.

Authors:  Jessica L Mester; Amanda K Tilot; Lisa A Rybicki; Thomas W Frazier; Charis Eng
Journal:  Eur J Hum Genet       Date:  2011-02-23       Impact factor: 4.246

4.  Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1.

Authors:  M Lammert; J M Friedman; H J Roth; R E Friedrich; L Kluwe; D Atkins; T Schooler; V-F Mautner
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

5.  Macrocephaly in neurofibromatosis type 1: a sign post for optic pathway gliomas?

Authors:  Christina Schindera; Kevin Wingeier; Barbara Goeggel Simonetti; Miriam Diepold; Claude B Nauer; Johannes Fleischhauer; Maja Steinlin
Journal:  Childs Nerv Syst       Date:  2011-08-07       Impact factor: 1.475

6.  Vascular rupture-a rare lethal complication of neurofibromatosis v. Recklinghausen.

Authors:  M Kettner; P Schmidt; S A Padosch
Journal:  Forensic Sci Med Pathol       Date:  2007-10-02       Impact factor: 2.007

7.  Craniofacial bone alterations in patients with neurofibromatosis type 1.

Authors:  Julie Chauvel-Picard; Laurence Lion-Francois; Pierre-Aurélien Beuriat; Christian Paulus; Alexandru Szathmari; Carmine Mottolese; Arnaud Gleizal; Federico Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-06-25       Impact factor: 1.475

8.  Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.

Authors:  Balazs Hegedus; Tu-Hsueh Yeh; Da Yong Lee; Ryan J Emnett; Jia Li; David H Gutmann
Journal:  Hum Mol Genet       Date:  2008-07-09       Impact factor: 6.150

Review 9.  Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1.

Authors:  Steven D Rhodes; Feng-Chun Yang
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

10.  Sarcomas in children with neurofibromatosis type 1-poor prognosis despite aggressive combined therapy in four patients treated in a single oncological institution.

Authors:  Ewa Bien; Teresa Stachowicz-Stencel; Danuta Sierota; Katarzyna Polczynska; Anna Szolkiewicz; Joanna Stefanowicz; Elzbieta Adamkiewicz-Drozynska; Piotr Czauderna; Wojciech Kosiak; Miroslawa Dubaniewicz-Wybieralska; Ewa Izycka-Swieszewska; Anna Balcerska
Journal:  Childs Nerv Syst       Date:  2007-07-13       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.